Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Barriga FM"'
Autor:
Barriga FM; Systems Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. fbarriga@vhio.net., Lowe SW; Cancer Biology and Genetics Program and Howard Hughes Medical Institute, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Nature protocols [Nat Protoc] 2024 May; Vol. 19 (5), pp. 1381-1399. Date of Electronic Publication: 2024 Feb 07.
Autor:
Tsanov KM; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Barriga FM; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Ho YJ; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alonso-Curbelo D; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Institute for Research in Biomedicine (IRB), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Livshits G; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Baslan T; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Biomedical Sciences, School of Veterinary Medicine, The University of Pennsylvania, Philadelphia, PA, USA., Simon J; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tian S; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wuest AN; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Luan W; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wilkinson JE; Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI, USA., Masilionis I; Computational & Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dimitrova N; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iacobuzio-Donahue CA; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chaligné R; Computational & Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pe'er D; Computational & Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Massagué J; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lowe SW; Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 18. Date of Electronic Publication: 2024 Mar 18.
Autor:
Burdziak C; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Alonso-Curbelo D; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain., Walle T; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany., Reyes J; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Barriga FM; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Haviv D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Xie Y; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Zhao Z; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Zhao CJ; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA., Chen HA; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Chaudhary O; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Masilionis I; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Choo ZN; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Gao V; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Luan W; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Wuest A; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ho YJ; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Wei Y; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec H3A 1A3, Canada., Quail DF; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec H3A 1A3, Canada., Koche R; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Mazutis L; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Institute of Biotechnology, Life Sciences Centre, Vilnius University, 02158 Vilnius, Lithuania., Chaligné R; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Nawy T; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lowe SW; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2023 May 12; Vol. 380 (6645), pp. eadd5327. Date of Electronic Publication: 2023 May 12.
Autor:
Barriga FM; Cancer Genome Engineering Lab, VHIO, Barcelona, Spain. fbarriga@vhio.net.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2023 May; Vol. 23 (5), pp. 271.
Autor:
Domingo-Muelas A; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain., Duart-Abadia P; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain., Morante-Redolat JM; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain., Jordán-Pla A; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain., Belenguer G; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain., Fabra-Beser J; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain., Paniagua-Herranz L; Departamento de Bioquímica y Biología Molecular, Universidad Complutense de Madrid (UCM), Madrid, Spain.; Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid, Spain.; Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Pérez-Villalba A; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain., Álvarez-Varela A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Barriga FM; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Gil-Sanz C; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain., Ortega F; Departamento de Bioquímica y Biología Molecular, Universidad Complutense de Madrid (UCM), Madrid, Spain.; Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid, Spain.; Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Batlle E; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. eduard.batlle@irbbarcelona.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. eduard.batlle@irbbarcelona.org.; ICREA, Barcelona, Spain. eduard.batlle@irbbarcelona.org., Fariñas I; Departamento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Valencia, Spain. isabel.farinas@uv.es.; Instituto de Biotecnología y Biomedicina (BIOTECMED), Universidad de Valencia, Valencia, Spain. isabel.farinas@uv.es.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain. isabel.farinas@uv.es.
Publikováno v:
Nature communications [Nat Commun] 2023 Jan 23; Vol. 14 (1), pp. 373. Date of Electronic Publication: 2023 Jan 23.
Autor:
Kim JK; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Wu C; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Del Latto M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Gao Y; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Choi SH; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Kierstead M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Gabriel Sauvé CE; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Firat C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Perez AC; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sillanpaa J; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Chen CT; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lawrence KE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Paty PB; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Barriga FM; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Wilkinson JE; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sawyers CL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lowe SW; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., García-Aguilar J; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Romesser PB; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Smith JJ; Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Publikováno v:
Cell reports methods [Cell Rep Methods] 2022 Nov 23; Vol. 2 (12), pp. 100353. Date of Electronic Publication: 2022 Nov 23 (Print Publication: 2022).
Autor:
Barriga FM; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tsanov KM; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ho YJ; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sohail N; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang A; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Baslan T; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wuest AN; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Del Priore I; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, New York, NY, USA., Meškauskaitė B; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Livshits G; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alonso-Curbelo D; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Simon J; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chaves-Perez A; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bar-Sagi D; Department of Biochemistry, New York University School of Medicine, New York, NY, USA., Iacobuzio-Donahue CA; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Notta F; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Division of Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Chaligne R; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sharma R; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pe'er D; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lowe SW; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. lowes@mskcc.org.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. lowes@mskcc.org.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Nov; Vol. 3 (11), pp. 1367-1385. Date of Electronic Publication: 2022 Nov 07.
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.
Autor:
Álvarez-Varela A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Novellasdemunt L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Barriga FM; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hernando-Momblona X; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Cañellas-Socias A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Cano-Crespo S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Sevillano M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Cortina C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Stork D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Morral C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Turon G; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Slebe F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Jiménez-Gracia L; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Caratù G; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Jung P; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Munich, Institute of Pathology, Ludwig Maximilian University, Munich, Germany., Stassi G; Department of Surgical Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy., Heyn H; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Tauriello DVF; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Mateo L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Tejpar S; Molecular Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium., Sancho E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Stephan-Otto Attolini C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Batlle E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. eduard.batlle@irbbarcelona.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. eduard.batlle@irbbarcelona.org.; ICREA, Barcelona, Spain. eduard.batlle@irbbarcelona.org.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1052-1070. Date of Electronic Publication: 2022 Jun 30.
Autor:
Choi SH; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Kim JK; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Chen CT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Wu C; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Marco MR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Barriga FM; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York., O'Rourke K; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill-Cornell Medical College, New York, New York., Pelossof R; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Qu X; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Chang Q; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Smith JJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Sanchez-Vega F; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Garcia-Aguilar J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2022 Aug 05; Vol. 20 (8), pp. 1305-1319.
Autor:
Sánchez-Rivera FJ; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Diaz BJ; Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA., Kastenhuber ER; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Schmidt H; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Katti A; Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA., Kennedy M; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, New York, NY, USA., Tem V; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ho YJ; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leibold J; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medical Oncology and Pneumology, University Hospital Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence EXC 2180 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Paffenholz SV; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, New York, NY, USA., Barriga FM; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chu K; Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA., Goswami S; Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Wuest AN; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Simon JM; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tsanov KM; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chakravarty D; Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang H; Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leslie CS; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lowe SW; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dow LE; Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. lud2005@med.cornell.edu.; Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA. lud2005@med.cornell.edu.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA. lud2005@med.cornell.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2022 Jun; Vol. 40 (6), pp. 862-873. Date of Electronic Publication: 2022 Feb 14.